Control of mucus hypersecretion by small polycationic peptides

K. C. Kim (Philadelphia, United States Of America)

Source: Annual Congress 2010 - Models of airways disease

Session: Models of airways disease
Session type: E-Communication Session
Number: 3705

Disease area: Airway diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. C. Kim (Philadelphia, United States Of America). Control of mucus hypersecretion by small polycationic peptides. Eur Respir J 2010; 36: Suppl. 54, 3705

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Vasoactive intestinal peptide receptors in the airways of smokers with chronic bronchitis Source: Eur Respir J 2004; 24: 958-963 Year: 2004
Club cell 10-kDa protein attenuates airway mucus hypersecretion and inflammation Source: Eur Respir J 2014; 44: 1002-1010 Year: 2014
Inhibitory effect of naringenin in airway mucus hypersecretion and the possible mechanism Source: International Congress 2018 – Paediatric respiratory infections: mechanistic insights and clinical outcomes Year: 2018
Mucus secretion by tracheal submucosal glands is induced by relaxing not by stretching Source: Annual Congress 2008 - Pathophysiology of respiratory diseases Year: 2008
Effect of sildenafil on mucus hypersecretion of rat airway Source: Eur Respir J 2007; 30: Suppl. 51, 523s Year: 2007
EGTA treatment of human airways in vitro unmasks M1/MUC5AC mucin in submucosal glands Source: Eur Respir J 2001; 18: 176-183 Year: 2001
The potential interaction of MARCKS-related peptide and diltiazem on acrolin-induced airway mucus hypersecretion in rats Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung Year: 2013
Peptidergic control of mucus secretion studied in human tracheal gland cells Source: Eur Respir J 2001; 18: Suppl. 33, 77s Year: 2001
Distribution of vasoactive intestinal peptide( VIP)- and substance P (SP)- containing innervation in bronchi of patients with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 128s Year: 2004
Regulation of MUC5AC mucin secretion by depletion of AQP5 in human airway submucosal gland cells Source: Eur Respir J 2006; 28: Suppl. 50, 756s Year: 2006
Thrombin stimulates mucin secretion from airway epithelial cells Source: Eur Respir J 2002; 20: Suppl. 38, 570s Year: 2002
TLR4 mediates LPS-induced mucus hypersecretion in rat airway Source: Annual Congress 2007 - Epithelial networks in the airways Year: 2007
Concentration of vasoactive intestinal peptide (VIP) and substance P (SP) in bronchi of patients with mild to moderate bronchial asthma Source: Eur Respir J 2005; 26: Suppl. 49, 583s Year: 2005
Critical role of cytosolic phospholipase A2? in bronchial mucus hypersecretion in CFTR-deficient mice Source: Eur Respir J 2010; 36: 1120-1130 Year: 2010
Intranasal steroids decrease eosinophils but not mucin expression in nasal polyps Source: Eur Respir J 2004; 24 : 594-600 Year: 2004
Genetic influence on chronic mucus hypersecretion – a twin study Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008
Assessing mucus secretion in murine tracheal explants Source: Eur Respir J 2002; 20: Suppl. 38, 484s Year: 2002
Chronic mucus hypersecretion in severe asthma Source: International Congress 2017 – Techniques to treat asthma Year: 2017